p53-family proteins are regulated by interacting partners such as MDMs and mutant p53.

p53-family protein–protein interactions have a central role in cancer development.

p53-family protein–protein interactions are appealing targets for cancer therapy.

Yeast has contributed to the knowledge of p53-family protein–protein interactions.

Anticancer candidates have emerged from yeast by targeting p53-family interactions.